Joel Greenblatt Corcept Therapeutics Inc Transaction History

Gotham Asset Management, LLC

$11.5 Billion
Q1 2025

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Gotham Asset Management, LLC holds 17,423 shares of CORT stock, worth $1.26 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

17,423

Previous 19,137 8.96%

Holding current value

$1.26 Million

Previous $964,000 106.43%

% of portfolio

0.02%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$49.85 - $114.22 $85,442 - $195,773	-1,714 Reduced 8.96%	17,423 $1.99 Million
Q4 2024 Feb 14, 2025	BUY	$44.66 - $60.85 $23,357 - $31,824	523 Added 2.81%	19,137 $964,000
Q3 2024 Nov 14, 2024	SELL	$29.51 - $46.26 $187,122 - $293,334	-6,341 Reduced 25.41%	18,614 $861,000
Q2 2024 Aug 14, 2024	SELL	$22.21 - $34.48 $304,654 - $472,962	-13,717 Reduced 35.47%	24,955 $810,000
Q1 2024 May 15, 2024	BUY	$21.1 - $27.46 $443,289 - $576,907	21,009 Added 118.94%	38,672 $974,000
Q4 2023 Feb 14, 2024	SELL	$24.82 - $32.88 $1,811 - $2,400	-73 Reduced 0.41%	17,663 $573,000
Q3 2023 Nov 14, 2023	SELL	$21.97 - $33.8 $89,330 - $137,430	-4,066 Reduced 18.65%	17,736 $483,000
Q2 2023 Aug 14, 2023	SELL	$21.44 - $25.15 $158,763 - $186,235	-7,405 Reduced 25.35%	21,802 $485,000
Q1 2023 May 15, 2023	SELL	$19.2 - $24.47 $277,593 - $353,787	-14,458 Reduced 33.11%	29,207 $632,000
Q4 2022 Feb 14, 2023	BUY	$19.95 - $29.96 $109,924 - $165,079	5,510 Added 14.44%	43,665 $886,000
Q3 2022 Nov 14, 2022	SELL	$24.7 - $29.12 $226,400 - $266,913	-9,166 Reduced 19.37%	38,155 $978,000
Q2 2022 Aug 15, 2022	SELL	$17.33 - $25.3 $36,722 - $53,610	-2,119 Reduced 4.29%	47,321 $1.13 Million
Q1 2022 May 16, 2022	BUY	$16.53 - $25.21 $9,818 - $14,974	594 Added 1.22%	49,440 $1.11 Million
Q4 2021 Feb 14, 2022	BUY	$17.1 - $23.34 $517,770 - $706,711	30,279 Added 163.08%	48,846 $967,000
Q3 2021 Nov 15, 2021	BUY	$19.68 - $22.53 $62,739 - $71,825	3,188 Added 20.73%	18,567 $365,000
Q2 2021 Aug 16, 2021	SELL	$19.97 - $24.43 $27,418 - $33,542	-1,373 Reduced 8.2%	15,379 $338,000
Q1 2021 May 17, 2021	SELL	$23.49 - $30.56 $230,460 - $299,824	-9,811 Reduced 36.93%	16,752 $399,000
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $282,273 - $459,240	-16,822 Reduced 38.77%	26,563 $695,000
Q3 2020 Nov 16, 2020	BUY	$12.46 - $19.98 $179,100 - $287,192	14,374 Added 49.55%	43,385 $755,000
Q2 2020 Aug 13, 2020	SELL	$11.0 - $18.26 $476,652 - $791,242	-43,332 Reduced 59.9%	29,011 $488,000
Q1 2020 May 15, 2020	SELL	$10.11 - $14.04 $58,547 - $81,305	-5,791 Reduced 7.41%	72,343 $860,000
Q4 2019 Feb 14, 2020	BUY	$12.06 - $16.96 $357,868 - $503,271	29,674 Added 61.23%	78,134 $945,000
Q3 2019 Nov 14, 2019	SELL	$10.41 - $14.66 $288,638 - $406,477	-27,727 Reduced 36.39%	48,460 $685,000
Q2 2019 Aug 14, 2019	SELL	$9.78 - $12.76 $387,698 - $505,831	-39,642 Reduced 34.22%	76,187 $849,000
Q1 2019 May 15, 2019	SELL	$10.03 - $15.71 $69,848 - $109,404	-6,964 Reduced 5.67%	115,829 $1.36 Million
Q4 2018 Feb 14, 2019	BUY	$11.29 - $17.19 $751,157 - $1.14 Million	66,533 Added 118.26%	122,793 $1.64 Million
Q3 2018 Nov 14, 2018	SELL	$12.27 - $15.65 $168,847 - $215,359	-13,761 Reduced 19.65%	56,260 $789,000
Q2 2018 Aug 14, 2018	BUY	$15.3 - $19.69 $754,427 - $970,894	49,309 Added 238.07%	70,021 $1.1 Million
Q1 2018 May 15, 2018	BUY	$14.59 - $25.5 $41,990 - $73,389	2,878 Added 16.14%	20,712 $341,000
Q4 2017 Feb 14, 2018	SELL	$15.77 - $20.72 $766,674 - $1.01 Million	-48,616 Reduced 73.16%	17,834 $322,000
Q3 2017 Nov 14, 2017	BUY	$12.3 - $19.3 $817,335 - $1.28 Million	66,450	66,450 $1.28 Million

Others Institutions Holding CORT

# of Institutions

469

Shares Held

83.4M

Call Options Held

1.42M

Put Options Held

2.75M

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.74B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account